180 related articles for article (PubMed ID: 25387093)
1. Dendritic cell reconstitution is associated with relapse-free survival and acute GVHD severity in children after allogeneic stem cell transplantation.
Elze MC; Ciocarlie O; Heinze A; Kloess S; Gardlowski T; Esser R; Klingebiel T; Bader P; Huenecke S; Serban M; Köhl U; Hutton JL
Bone Marrow Transplant; 2015 Feb; 50(2):266-73. PubMed ID: 25387093
[TBL] [Abstract][Full Text] [Related]
2. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.
Mager K; Wehner R; Bahr F; Oelschlägel U; Platzbecker U; Wermke M; Shayegi N; Middeke JM; Radke J; Röllig C; Schetelig J; Thiede C; Ehninger G; Schmitz M; Bornhäuser M; Tuve S
Transplantation; 2012 Jun; 93(12):1270-5. PubMed ID: 22643330
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of plasmacytoid dendritic cell reconstitution and its relationship with cGVHD and relapse after haploidentical hematopoietic stem cell transplantation].
Wu JY; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):342-7. PubMed ID: 17493344
[TBL] [Abstract][Full Text] [Related]
5. Enumeration of bone marrow plasmacytoid dendritic cells by multiparameter flow cytometry as a prognostic marker following allogeneic hematopoietic stem cell transplantation.
Su RJ; Green R; Chen M
Blood Cells Mol Dis; 2018 Mar; 69():107-112. PubMed ID: 29137845
[TBL] [Abstract][Full Text] [Related]
6. [Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic HLA mismatched/ haploidentical hematopoietic stem cell transplantation].
Wu JY; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):73-7. PubMed ID: 17650664
[TBL] [Abstract][Full Text] [Related]
7. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
[TBL] [Abstract][Full Text] [Related]
8. Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.
Waller EK; Logan BR; Harris WA; Devine SM; Porter DL; Mineishi S; McCarty JM; Gonzalez CE; Spitzer TR; Krijanovski OI; Linenberger ML; Woolfrey A; Howard A; Wu J; Confer DL; Anasetti C
J Clin Oncol; 2014 Aug; 32(22):2365-72. PubMed ID: 24982459
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
10. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
11. Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation.
Mohty M; Blaise D; Faucher C; Bardou VJ; Gastaut JA; Viens P; Olive D; Gaugler B
Leukemia; 2005 Jan; 19(1):1-6. PubMed ID: 15526026
[TBL] [Abstract][Full Text] [Related]
12. Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.
Shin SH; Kim JH; Jeon YW; Yoon JH; Yahng SA; Lee SE; Choi YS; Kim DY; Lee JH; Lee S; Kim HJ; Min CK; Lee JW; Lee KH; Min WS; Kim YJ; Lee JH
Biol Blood Marrow Transplant; 2015 Feb; 21(2):342-9. PubMed ID: 25459640
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation.
Varanasi PR; Ogonek J; Luther S; Dammann E; Stadler M; Ganser A; Borchers S; Hambach L; Weissinger EM
PLoS One; 2019; 14(3):e0213739. PubMed ID: 30889204
[TBL] [Abstract][Full Text] [Related]
14. A Low Level of Plasmacytoid Dendritic Cells at Engraftment Is a Valuable Prognostic Indicator in Children Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Li B; Meng L; Tian Y; Ling J; Hu Y; Lu Q; Gao L; Wu S; Zhang Y; Hu S
Transplant Cell Ther; 2021 Jul; 27(7):611.e1-611.e12. PubMed ID: 33895404
[TBL] [Abstract][Full Text] [Related]
15. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
[TBL] [Abstract][Full Text] [Related]
16. Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.
Shaw BE; Apperley JF; Russell NH; Craddock C; Liakopoulou E; Potter MN; Wynn R; Gibson B; Pearce RM; Kirkland K; Lee J; Madrigal JA; Cook G; Byrne JL
Br J Haematol; 2011 Apr; 153(2):244-52. PubMed ID: 21382020
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.
Bleakley M; Heimfeld S; Loeb KR; Jones LA; Chaney C; Seropian S; Gooley TA; Sommermeyer F; Riddell SR; Shlomchik WD
J Clin Invest; 2015 Jul; 125(7):2677-89. PubMed ID: 26053664
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
19. Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease.
Reddy V; Iturraspe JA; Tzolas AC; Meier-Kriesche HU; Schold J; Wingard JR
Blood; 2004 Jun; 103(11):4330-5. PubMed ID: 14962904
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation.
Fagnoni FF; Oliviero B; Giorgiani G; De Stefano P; Dehò A; Zibera C; Gibelli N; Maccario R; Da Prada G; Zecca M; Locatelli F
Blood; 2004 Jul; 104(1):281-9. PubMed ID: 15010368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
